Skip to main content
Clinical Trials/NCT04066010
NCT04066010
Completed
N/A

Optimizing the Approach of Mobile Application Use to Improve Medication Adherence in Patients With Hypertension

Mercer University0 sites55 target enrollmentOctober 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Medication Adherence
Sponsor
Mercer University
Enrollment
55
Primary Endpoint
Blood pressure
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The purpose of this study was to determine the effectiveness of using a custom-designed mobile application to improve blood pressure (BP) and promote adherence to antihypertensive medication regimens. This was a prospective, multicenter, randomized controlled trial. Patients were randomized to an intervention or control group for three months. Antihypertensive medication refill history was assessed three months before, during and three months after the study period. Continuous outcome measures investigated were systolic/diastolic BP and medication refill history, using the cumulative medication gap (CMG) score.

Registry
clinicaltrials.gov
Start Date
October 2016
End Date
November 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years of age
  • Diagnosed with hypertension as evidenced by diagnosis codes or chart documentation
  • Prescribed at least one antihypertensive for a minimum of three months prior to enrollment
  • Have access to an Android mobile device with data capabilities
  • Consent to using the application on their device

Exclusion Criteria

  • Do not read or speak English
  • Unable to read and sign the informed consent or Health Insurance Privacy and Accountability Act (HIPAA) waiver
  • Too ill or cognitively impaired to participate

Outcomes

Primary Outcomes

Blood pressure

Time Frame: 6 months

This was assessed by measuring the change of systolic and diastolic blood pressure

Medication adherence

Time Frame: 6 months

This was assessed based on cumulative medication gap (CMG)

Similar Trials